Koers Bud Genius, Inc. Other OTC
Aandelen
RIGH
US76657X1110
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | 0,04 0,04 | Marktkapitalisatie | 11,25K 10,56K |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | - 0 | Nettowinst (verlies) 2010 | - 0 | EV/omzet 2009 | - |
Nettoschuld 2009 | 489K 459K | Nettoschuld 2010 | 396K 372K | EV/omzet 2010 | 9.639.795 x |
K/w-verhouding 2009 |
-23,5
x | K/w-verhouding 2010 |
-
| Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 61,59% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,17% | 42,86 mld. | |
+10,92% | 42,74 mld. | |
+44,30% | 41,36 mld. | |
-6,20% | 27,68 mld. | |
+5,23% | 25,15 mld. | |
-24,79% | 18,63 mld. | |
+26,69% | 12,37 mld. | |
-3,13% | 11,92 mld. | |
+6,57% | 11,21 mld. |